Dr. Robert T. Chow, MD

Dr. Chow practices at Maryland General Clinical Practice Group, Inc. in Baltimore, Maryland.

Dr. Chow's NPI, 1447200902, was assigned on May 12, 2006. Dr. Chow graduated from Perelman School of Med at the University of Pennsylvania in 1984. Dr. Chow holds Maryland license D34851.

Dr. Chow's primary practice is Maryland General Clinical Practice Group, Inc., at 822 Linden Ave, Baltimore, MD 21201 in Baltimore City. The practice phone is (443) 462-5093.

Dr. Chow's primary practice is Maryland General Clinical Practice Group, Inc. in Baltimore, Maryland. Dr. Chow is also affiliated with University of Maryland Medical Center. The medical group on file is UM Community Medical Group. Dmand AI also links Dr. Chow to 1 more hospital and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chow practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Chow's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Chow is licensed in Maryland.

CMS data shows 247 Medicare services from Dr. Chow across 3 procedure codes in 2024, for 88 Medicare patients. Medicare paid $10,851 for them. Every service was in an office.

CMS counts 88 Medicare patients who saw Dr. Chow in 2024. The largest group is 65 to 74, with 33 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 28% are also on Medicaid. Their average risk score is 2.28, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chow's median patient age at 65, with 46% women.

In 2024, Dr. Chow wrote 1,905 Medicare Part D claims for 124 patients. 88% of them were for generic drugs. CMS names the drug for 1,407 of them, across 53 drugs with 11 or more claims each, at $160,642 in total drug cost. In 2023, CMS named 1,364 claims across 52 drugs.

Dr. Chow accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 8 papers to Dr. Chow, published from 2015 to 2024. 2020 was the busiest year, with 2. Dr. Chow has published most often in J Community Hosp Intern Med Perspect. Dr. Chow's most frequent co-authors are Richard L. Alweis, MD, Reyaz U. Haque, MD and Sapna P. Kuehl, MD.

CMS Open Payments shows 82 general payments to Dr. Chow from 22 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 67% of the total. Gilead Sciences, Inc. paid the most, $8,058.

Dr. Chow graduated from Perelman School of Med at the University of Pennsylvania in 1984.